SCHEMBL5982913

SCHEMBL5982913

N/C(=C/c1ccccc1)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.56
AKR1C1 Q04828 1/20 0.54
MCL1 Q07820 1/20 0.52
CYP2C9 P11712 2/20 0.48
CYP3A4 P08684 2/20 0.48
RECQL P46063 3/20 0.47
TP53 P04637 1/20 0.47
HTT P42858 2/20 0.46
FBP1 P09467 3/20 0.45
ALDH1A1 P00352 3/20 0.45
TSHR P16473 2/20 0.45
MAPT P10636 3/20 0.43
LMNA P02545 2/20 0.43
HDAC3 O15379 1/20 0.43
TNKS O95271 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HCAR2 Q8TDS4 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL792779 1.00 AKR1C3 (0.56) AKR1C3AKR1C1MCL1CYP2C9CYP3A4
SCHEMBL1081471 1.00 AKR1C3 (0.56) AKR1C3AKR1C1MCL1CYP2C9CYP3A4
SCHEMBL11594648 0.86 MCL1 (0.57) AKR1C3AKR1C1MCL1CYP2C9CYP3A4
SCHEMBL20049735 0.86 MCL1 (0.57) AKR1C3AKR1C1MCL1CYP2C9CYP3A4
SCHEMBL17397066 0.86 MCL1 (0.57) AKR1C3AKR1C1MCL1CYP2C9CYP3A4
SCHEMBL181651 0.86 MCL1 (0.52) AKR1C3AKR1C1MCL1CYP2C9CYP3A4
SCHEMBL7044923 0.85 MCL1 (0.48) AKR1C3AKR1C1MCL1FBP1ALDH1A1
SCHEMBL859579 0.85 MCL1 (0.48) AKR1C3AKR1C1MCL1FBP1ALDH1A1
SCHEMBL11729242 0.82 EGFR (0.53) AKR1C3TP53ALDH1A1HSD17B10KDM4E
SCHEMBL6940611 0.82 AKR1C3 (0.57) AKR1C3AKR1C1MCL1RECQLHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449544-B2 p21 peptides CYCLACEL LIMITED (GB) 2008-11-11 US disclosed
US-7449544-B2 p21 peptides CYCLACEL LIMITED (GB) 2008-11-11 US disclosed
EP-1656390-A2 COMPOSITIONS OF LIPOPEPTIDE ANTIBIOTIC DERIVATIVES AND METHODS OF USE THEREOF MIGENIX INC. (CA) 2006-05-17 EP disclosed
WO-2005000878-A2 COMPOSITIONS OF LIPOPEPTIDE ANTIBIOTIC DERIVATIVES AND METHODS OF USE THEREOF MIGENIX INC. (CA) 2005-01-06 WO disclosed